Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas

Journal of Comparative Pathology

Volumn 131, Issue 1, 2004, Pages 70-76

  Borzacchiello, G ^a   Paciello, O ^a   Papparella, S ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Confocal laser scanning microscopy; Cyclooxygenase 1 and 2; Dog; Nasal carcinoma; Tumour

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CARCINOGENESIS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DOG; DYSPLASIA; GENE OVEREXPRESSION; NONHUMAN; NOSE CARCINOMA; NOSE MUCOSA; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL;

ANIMALIA; CANIS FAMILIARIS;

EID: 2942617208     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2004.01.006     Document Type: Article

References (42)

1. Adams, W. M., Withrow, S. J., Walshaw, R., Turrell, J. M., Evans, S. M., Walker, M. A. and Kurzman, I. D. (1987). Radiotherapy of malignant nasal tumors in 67 dogs. Journal of the American Veterinary Medical Association, 191, 311-315.
2. Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., Snover, D. C., Church, T. R., Allen, J. I., Beach, M., Beck, G. J., Bond, J. H., Byers, T., Greenberg, E. R., Mandel, J. S., Marcon, N., Mott, L. A., Pearson, L., Saibil, F. and van Stolk, R. U. (2003). A randomized trial of aspirin to prevent colorectal adenomas. New England Journal of Medicine, 10, 891-899.
3. Beck, E. R. and Withrow, S. J. (1985). Tumors of the canine nasal cavity. Veterinary Clinics of North America: Small Animal Practice, 15, 521-523.
4. Borzacchiello, G., Ambrosio, V., Perillo, A., Galati, P. and Roperto, F. (2003). Cyclooxygenase-1 and -2 expression in urothelial carcinomas of cows. Veterinary Pathology, 40, 455-459.
5. 2 synthesis in cultured bladder cancer cells. Pathology, 33, 469-474.
6. Chapple, K. S., Cartwright, E. J., Hawcroft, G., Tisbury, A., Bonifer, C., Scott, N., Windsor, A. C., Guillou, P. J., Markham, A. F., Coletta, P. L. and Hull, M. A. (2000). Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. American Journal of Pathology, 156, 545-553.
7. Dorè, M., Lanthier, I. and Sirois, J. (2003). Cyclooxygenase-2 expression in canine mammary tumors. Veterinary Pathology, 40, 207-212.
8. Dungworth, D. L., Hauser, B., Hahn, F. F., Wilson, D. W., Haenichen, T. and Harkema, J. R. (1999). Histological classification of the tumors of the respiratory system of domestic animals. World Health Organization International Histological Classification of Tumors of Domestic Animals, 6, 16-21.
9. Gupta, R. A., Tejada, L. V., Tong, B. J., Das, S. K., Morrow, J. D., Dey, S. K. and DuBois, R. N. (2003). Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Research, 63, 906-911.
10. Hayes, H. M., Wilson, G. P. and Fraumeni, J. F. (1982). Carcinoma of the nasal cavity and paranasal sinuses in dogs: descriptive epidemiology. Cornell Veterinarian, 72, 168-179.
11. Herschman, H. R. (1996). Prostaglandin synthase 2. Biochimica et Biophysica Acta, 1299, 125-140.
12. Khan, M. K. N., Knapp, D. W., Denicola, D. and Harris, K. R. (2000). Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. American Journal of Veterinary Research, 61, 478-481.
13. Khan, M. K. N., Stanfield, K. M., Trajkovic, D. and Knapp, D. W. (2001). Expression of cyclooxygenase-2 in canine renal cell carcinoma. Veterinary Pathology, 38, 116-119.
14. Kishi, K., Petersen, S., Petersen, C., Hunter, N., Masferrer, J. L., Tofilon, P. J. and Milas, L. (2000). Preferential enhancement of tumor radioresponse by a COX-2 inhibitor. Cancer Research, 60, 1326-1331.
15. Knapp, D. W., Richardson, R. C., Bottoms, G. D., Teclaw, R. and Chan, T. C. (1992). Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors. Cancer Chemotherapy and Pharmacology, 29, 214-218.
16. Knapp, D. W., Richardson, R. C., Chan, R. C., Bottoms, G. D., Widmer, W. R., Denicola, D. B., Teclaw, R., Bonney, P. L. and Kuczek, T. (1994). Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. Journal of Veterinary Internal Medicine, 8, 273-278.
17. Koki, A. T., Khan, N. K., Woerner, B. M., Seibert, K., Harmon, J. L., Dannenberg, A. J., Sostow, R. A. and Masferrer, J. L. (2002). Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. Prostaglandins, Leukotrienes and Fatty Acids, 66, 13-18.
18. Legendre, A. M. (1983). Canine nasal and paranasal sinus tumors. Journal of the American Animal Hospital Association, 19, 115-123.
19. McEntee, M. E., Cates, J. M. and Nielsen, N. (2002). Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Veterinary Pathology, 39, 428-436.
20. Meade, E. A., McIntyre, T. E., Zimmerman, G. A. and Prescott, S. M. (1999). Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. Journal of Biological Chemistry, 274, 8328-8334.
21. Milas, L., Kischi, K., Hunter, N., Masferrer, J. L. and Tofilon, P. J. (1999). Enhancement of tumor response to γ -irradiation by an inhibitor of cyclooxygenase-2 enzyme. Journal of the National Cancer Institute, 91, 1501-1504.
22. Mohammed, S. I., Bennett, P. F., Craig, B. A., Glickman, N. W., Mutsaers, A. J., Snyder, P. W., Widmer, W. R., Degortari, A. E., Bonney, P. L. and Knapp, D. W. (2002). Effects of cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Research, 62, 356-358.
23. Mohammed, S. I., Knapp, D. W., Bostwick, D. G., Foster, R. S., Khan, K. N., Masferrer, J. L., Woerner, B. M., Snyder, P. W. and Koki, A. T. (1999). Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Research, 59, 5647-5650.
24. Morita, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L. and Smith, W. L. (1995). Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. Journal of Biological Chemistry, 270, 10902-10908.
25. Okajima, E., Denda, A., Ozono, S., Takahama, M., Akai, H., Sasaki, Y., Kitayama, W., Wakabayashi, K. and Konishi, Y. (1998). Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas by n-butyl-n-(4-hydroxybutyl) nitrosamine. Cancer Research, 58, 3028-3031.
26. Paciello, O., Borzacchiello, G., Varricchio, E. and Papparella, S. (2002). Expression of peroxisome proliferator-activated receptor γ in canine nasal carcinomas: preliminary report. Proceedings of 20th Meeting of the European Society of Veterinary Pathology, 242.
27. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R. and Giardiello, F. M. (1995). The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109, 994-998.
28. Pestili de Almeida, E. M., Pichè, C., Sirois, J. and Dorè, M. (2001). Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. Journal of Histochemistry and Cytochemistry, 49, 867-875.
29. Ristimäki, A., Nieminem, O., Saukkonen, K., Hotakainen, K., Nordling, S. and Haglund, C. (2001). Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. American Journal of Pathology, 158, 849-853.
30. Smith, W. L., Garavito, M. R. and DeWitt, D. L. (1996). Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Journal of Biological Chemistry, 271, 33157-33160.
31. Subbaramaiah, K. and Dannenberg, A. J. (2003). Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends in Pharmacological Sciences, 24, 96-102.
32. Taketo, M. M. (1998a). Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). Journal of the National Cancer Institute, 90, 1529-1536.
33. Taketo, M. M. (1998b). Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). Journal of the National Cancer Institute, 90, 1609-1620.
34. Theisen, S. K., Hosgood, G. and Lewis, D. D. (1996). Intranasal tumors in dogs: diagnosis and treatment. Compendium on Continuing Education for the Practicing Veterinarian, 18, 131-138.
35. Thèon, A. P., Madewell, B. R., Harb, M. F. and Dungworth, D. L. (1993). Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. Journal of the American Veterinary Medical Association, 202, 1469-1475.
36. Thrall, D. E. and Harvey, C. E. (1983). Radiotherapy of malignant nasal tumors in 21 dogs. Journal of the American Veterinary Medical Association, 183, 663-666.
37. Tsujii, M. and Dubois, R. N. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
38. Tsujii, M., Kawano, S. and Dubois, R. N. (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proceedings of the National Academy of Sciences of the United States of America, 94, 3336-3340.
39. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. and Dubois, R. N. (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
40. Williams, C. S. and Dubois, R. N. (1996). Prostaglandin endoperoxide synthase: why two isoforms? American Journal of Physiology, 270, 393-400.
41. Williams, C. S., Mann, M. and DuBois, R. N. (1999). The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18, 7908-7916.
42. Wilson, D. W. and Dungworth, D. L. (2002). Tumors of the respiratory tract. In: Tumors of Domestic Animals, D. J. Meuten, Ed., Iowa State Press, Ames, pp. 365-377.